BrainsWay Ltd. (TLV:BWAY)
4,026.00
+162.00 (4.19%)
Mar 11, 2026, 3:05 PM IDT
BrainsWay Revenue
In the year 2025, BrainsWay had annual revenue of $52.23M USD with 27.33% growth. BrainsWay had revenue of $14.55M in the quarter ending December 31, 2025, with 27.43% growth.
Revenue
$52.23M
Revenue Growth
+27.33%
P/S Ratio
9.32
Revenue / Employee
$435.21K
Employees
120
Market Cap
1.52B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.23M | 11.21M | 27.33% |
| Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 31, 2019 | 23.10M | 6.70M | 40.89% |
| Dec 31, 2018 | 16.40M | 5.25M | 47.12% |
| Dec 31, 2017 | 11.15M | -379.00K | -3.29% |
| Dec 31, 2016 | 11.52M | 4.72M | 69.47% |
| Dec 31, 2015 | 6.80M | 3.42M | 101.18% |
| Dec 31, 2014 | 3.38M | 2.19M | 184.27% |
| Dec 31, 2013 | 1.19M | 1.10M | 1,282.56% |
| Dec 31, 2010 | 86.00K | 83.00K | 2,766.67% |
| Dec 31, 2009 | 3.00K | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| Bait Bakfar | 107.78M |
| Golden House | 46.05M |
BrainsWay News
- 19 hours ago - Uncovering Potential: BrainsWay's Earnings Preview - Benzinga
- 1 day ago - Earnings To Watch: BrainsWay Ltd (BWAY) Reports Q4 2025 Result - GuruFocus
- 6 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Benzinga
- 7 days ago - BrainsWay (BWAY) Announces Breakthrough in Depression Treatment - GuruFocus
- 7 days ago - Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment - GlobeNewsWire
- 7 days ago - Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment - Benzinga
- 14 days ago - BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 - GlobeNewsWire
- 19 days ago - BrainsWay (BWAY) Invests in Canadian Mental Health Clinics - GuruFocus